Dezhan Healthcare Company Limited (SHE:000813)
China · Delayed Price · Currency is CNY 2.800
-0.080 (-2.78%)
Nov 13, 2026, 3:04 PM CST
Dezhan Healthcare Company Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Cash & Equivalents | 690.84 | 1,806 | 2,531 | 2,796 | 2,599 | 1,474 |
Short-Term Investments | - | - | - | - | 400 | 600 |
Trading Asset Securities | 4.14 | 10.08 | - | - | - | 418.41 |
Cash & Short-Term Investments | 694.98 | 1,816 | 2,531 | 2,796 | 2,999 | 2,492 |
Cash Growth | -70.81% | -28.25% | -9.50% | -6.76% | 20.34% | -29.09% |
Accounts Receivable | 359.79 | 296.18 | 284.31 | 203.39 | 369.86 | 369.85 |
Other Receivables | 257.5 | 266.36 | 319.45 | 317.92 | 321.25 | 335.76 |
Receivables | 617.29 | 562.54 | 603.76 | 521.31 | 691.12 | 705.61 |
Inventory | 135.64 | 147.57 | 197.87 | 207.56 | 250.89 | 300.02 |
Prepaid Expenses | - | 3.53 | 0.01 | 0 | 1.5 | - |
Other Current Assets | 55.8 | 38.86 | 18.48 | 13.74 | 15.19 | 64.99 |
Total Current Assets | 1,504 | 2,568 | 3,351 | 3,539 | 3,958 | 3,563 |
Property, Plant & Equipment | 987.23 | 916.62 | 803.22 | 784.75 | 708.63 | 707.24 |
Long-Term Investments | 387.89 | 398.83 | 564.29 | 534.69 | 548.23 | 962.12 |
Goodwill | 244.89 | 244.89 | 289.71 | 289.71 | 198.3 | 198.3 |
Other Intangible Assets | 146.45 | 135.86 | 166.54 | 185.28 | 214.88 | 285 |
Long-Term Deferred Tax Assets | 17.76 | 21.41 | 31.2 | 15.05 | 24.65 | 31.06 |
Long-Term Deferred Charges | 106.47 | 118.09 | 87.52 | 16.75 | 14.71 | 19.77 |
Other Long-Term Assets | 1,349 | 468.1 | 26.52 | 13.35 | 8.92 | 11.79 |
Total Assets | 4,743 | 4,872 | 5,320 | 5,379 | 5,676 | 5,778 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Accounts Payable | 67.5 | 76.18 | 15.95 | 26.34 | 140.81 | 31.3 |
Accrued Expenses | 13.93 | 62.39 | 80.03 | 47.72 | 99.55 | 97.91 |
Short-Term Debt | - | - | 0.39 | 0.87 | - | - |
Current Portion of Long-Term Debt | 8 | 1 | - | - | - | - |
Current Portion of Leases | - | 7.25 | 3.47 | 2.07 | 2.17 | 5.27 |
Current Income Taxes Payable | 16.58 | 0 | 0.72 | 1.24 | 1.76 | 2.91 |
Current Unearned Revenue | 0.3 | 1.13 | 0.2 | 0.59 | 28.19 | 26.96 |
Other Current Liabilities | 56.46 | 7.85 | 9.11 | 18.38 | 62.32 | 85.76 |
Total Current Liabilities | 162.77 | 155.8 | 109.87 | 97.2 | 334.81 | 250.12 |
Long-Term Debt | 112.8 | 113.3 | - | - | - | - |
Long-Term Leases | 7.82 | 13.23 | 14.26 | 4.63 | 6.9 | 7.09 |
Long-Term Unearned Revenue | 3.43 | 4.53 | 6.09 | 7.65 | 9.34 | 11.1 |
Long-Term Deferred Tax Liabilities | 6.84 | 7.53 | 19.62 | 22.66 | 19.93 | 19.33 |
Other Long-Term Liabilities | 5.03 | 5.1 | 5.03 | 5 | 21.18 | 20.41 |
Total Liabilities | 298.69 | 299.5 | 154.88 | 137.15 | 392.16 | 308.05 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Common Stock | 801.23 | 801.23 | 869.08 | 869.08 | 930.52 | 945.61 |
Additional Paid-In Capital | 332.62 | 332.62 | 455.23 | 413.08 | 539.08 | 565.14 |
Retained Earnings | 3,488 | 3,592 | 3,937 | 3,958 | 3,871 | 3,918 |
Treasury Stock | - | - | -73.28 | - | -48.87 | -56.92 |
Comprehensive Income & Other | -89.75 | -90.19 | -30.4 | -2.05 | 0.54 | - |
Total Common Equity | 4,533 | 4,636 | 5,158 | 5,238 | 5,293 | 5,372 |
Minority Interest | -88.21 | -63.12 | 6.93 | 3.56 | -8.63 | 97.88 |
Shareholders' Equity | 4,444 | 4,573 | 5,165 | 5,241 | 5,284 | 5,470 |
Total Liabilities & Equity | 4,743 | 4,872 | 5,320 | 5,379 | 5,676 | 5,778 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Total Debt | 128.63 | 134.78 | 18.13 | 7.57 | 9.07 | 12.36 |
Net Cash (Debt) | 566.36 | 1,681 | 2,513 | 2,789 | 2,990 | 2,480 |
Net Cash Growth | -74.70% | -33.10% | -9.91% | -6.73% | 20.58% | -29.44% |
Net Cash Per Share | 0.27 | 0.79 | 1.17 | 1.28 | 1.35 | 1.11 |
Filing Date Shares Outstanding | 2,110 | 2,097 | 2,136 | 2,165 | 2,216 | 922 |
Total Common Shares Outstanding | 2,110 | 2,097 | 2,136 | 2,165 | 2,216 | 922 |
Working Capital | 1,341 | 2,412 | 3,241 | 3,442 | 3,623 | 3,313 |
Book Value Per Share | 2.15 | 2.21 | 2.41 | 2.42 | 2.39 | 5.83 |
Tangible Book Value | 4,141 | 4,255 | 4,702 | 4,763 | 4,879 | 4,889 |
Tangible Book Value Per Share | 1.96 | 2.03 | 2.20 | 2.20 | 2.20 | 5.30 |
Buildings | - | 732.91 | 748.6 | 721.86 | 561.5 | 402.97 |
Machinery | - | 424.14 | 396.21 | 377.74 | 360.82 | 359.36 |
Construction In Progress | - | 194.63 | 43.85 | 33.25 | 79.58 | 180.94 |